Showing results (351-360 of 675) with videos related to

Sort By:
Pageof 68
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Clinical Breast Cancer|February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriersTara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.
Contemporary Clinical Trials|September 18, 2024
Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist controlCarol J Fabian, Dinesh Pal Mudaranthakam, Byron Gajewski, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 1, 2023
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In SituAnne E O'Shea, Guy T Clifton, Na Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Susceptibility loci associated with prostate cancer progression and mortalityDavid J Gallagher, Joseph Vijai, Angel M Cronin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancersKenneth Offit, Shlomit Gilad, Shoshana Paglin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cellsStephen J Salipante, Matthew E Mealiffe, Jeremy Wechsler, et al.
American Journal of Medical Genetics. Part A|December 22, 2025
Subclinical Telomere Biology Disorder in Cancer Patients Heterozygous for the RTEL1 R1264H Founder VariantLauren G Banaszak, Elise Fiala, Ozge Ceyhan-Birsoy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity FrameworkBryce A Seifert, Jennifer L McGlaughon, Sarah A Jackson, et al.
International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.
Pageof 68